Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110128357B reveals a mild Cs2CO3-catalyzed route for pyrazine derivatives, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Advanced synthesis of alpha-isopropyl-3,4-dimethoxyphenylacetonitrile via patent CN113444020B. High-yield route for Verapamil intermediates with reduced toxicity and cost.
Discover the novel CN103172574A synthesis route for 2-substituted-4,6-dialkoxy pyrimidines. Achieve >99% purity with reduced waste and lower manufacturing costs.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Patent CN102304095B details a novel 5-step synthesis for Sulfadoxine, eliminating toxic catalysts and improving purity for cost-effective pharmaceutical manufacturing.
Patent CN101759625A details a robust synthesis for 2,4-dimethyl-5-formyl-1H-pyrrole-3-carboxylic acid, offering safer conditions and scalable production for global supply chains.
Patent CN110204547A reveals a safer two-step synthesis for 1,3-dimethyl uric acid, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102993024B reveals a safer sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine, offering high purity >98% and significant cost reduction in fine chemical manufacturing.
Patent CN1126743C details a novel synthesis of anticancer quinazoline derivatives, preventing vinyl polymerization and ensuring high-purity API intermediates for cost-effective manufacturing.
Novel two-step method for high-purity 3,3'-dimethyl-4,4'-biphenyldiol. Reduces environmental impact and enhances supply chain reliability for polymer monomers.
Novel patent CN119977815A details efficient synthesis for KRAS inhibitors. Offers cost reduction and scalable supply chain solutions for pharma intermediates.
Patent CN111875510B reveals a novel continuous synthesis route for aminoacetaldehyde dimethyl acetal, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101353328B details a green synthesis route for quinazoline intermediates, offering cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN112638855B enables high-purity pseudo-ionone via continuous Aldol condensation, offering cost reduction and supply reliability for fragrance and vitamin intermediates.
Novel route for N,5-dimethyl-2-oxazolamine using 1-methylurea eliminates toxic methyl iodide, offering cost reduction and safer supply chain for pharmaceutical manufacturing.
Patent CN106854161A details a green oxidation route for 3-4-dimethoxy-6-nitrobenzoic acid. This method ensures high purity and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN101481399A reveals a cost-effective route for 5'-O-DMTr-anhydrothymidine, offering significant supply chain advantages for radiopharmaceutical manufacturers.
Novel FeCl3-catalyzed reduction method for high-purity 2-aminopyrimidine compounds, eliminating toxic iron sludge and difficult impurities for scalable API manufacturing.